@drdimbas.bsky.social
Official guidelines agree, but they might soon change based on some recent studies showing no difference between bid and qd dtg when on RIF
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial
Our findings suggest that twice-daily dolutegravir might be unnecessary in people with HIV-associated tuberculosis.
www.thelancet.com
December 29, 2024 at 6:01 PM
Official guidelines agree, but they might soon change based on some recent studies showing no difference between bid and qd dtg when on RIF
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...